Literature DB >> 23464368

HIV-1 drug resistance: where do polymorphisms fit in?

Kristof Theys, Ana B Abecasis, Anne-Mieke Vandamme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23464368     DOI： 10.2217/fmb.13.10

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  8 in total

1.  Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.

Authors:  Michael E Abram; Renee R Ram; Nicolas A Margot; Tiffany L Barnes; Kirsten L White; Christian Callebaut; Michael D Miller
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

2.  Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors.

Authors:  Karolin Meixenberger; Kaveh Pouran Yousef; Maureen Rebecca Smith; Sybille Somogyi; Stefan Fiedler; Barbara Bartmeyer; Osamah Hamouda; Norbert Bannert; Max von Kleist; Claudia Kücherer
Journal:  Virol J       Date:  2017-11-14       Impact factor: 4.099

3.  Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool.

Authors:  Alejandro Pironti; Nico Pfeifer; Hauke Walter; Björn-Erik O Jensen; Maurizio Zazzi; Perpétua Gomes; Rolf Kaiser; Thomas Lengauer
Journal:  PLoS One       Date:  2017-04-10       Impact factor: 3.240

4.  Pre-existing singleton E138A mutations in the reverse transcriptase gene do not affect the efficacy of first-line antiretroviral therapy regimens using rilpivirine in human immunodeficiency virus-infected patients.

Authors:  Anna Kuznetsova; Aleksey Lebedev; Konstantin Gromov; Elena Kazennova; Maurizio Zazzi; Francesca Incardona; Anders Sönnerborg; Marina Bobkova
Journal:  Clin Case Rep       Date:  2022-02-03

5.  HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan.

Authors:  Hung-Chin Tsai; I-Tzu Chen; Kuan-Sheng Wu; Yu-Ting Tseng; Cheng-Len Sy; Jui-Kuang Chen; Shin-Jung Susan Lee; Yao-Shen Chen
Journal:  Oncotarget       Date:  2018-05-18

6.  Genetic Features of HIV-1 Integrase Sub-Subtype A6 Predominant in Russia and Predicted Susceptibility to INSTIs.

Authors:  Alina Kirichenko; Ilya Lapovok; Pavel Baryshev; David A M C van de Vijver; Jeroen J A van Kampen; Charles A B Boucher; Dimitrios Paraskevis; Dmitry Kireev
Journal:  Viruses       Date:  2020-07-31       Impact factor: 5.048

7.  Genetic divergence of HIV-1 B subtype in Italy over the years 2003-2016 and impact on CTL escape prevalence.

Authors:  Claudia Alteri; Lavinia Fabeni; Rossana Scutari; Giulia Berno; Domenico Di Carlo; Caterina Gori; Ada Bertoli; Alessandra Vergori; Ilaria Mastrorosa; Rita Bellagamba; Cristina Mussini; Manuela Colafigli; Francesco Montella; Alfredo Pennica; Claudio Maria Mastroianni; Enrico Girardi; Massimo Andreoni; Andrea Antinori; Valentina Svicher; Francesca Ceccherini-Silberstein; Carlo Federico Perno; Maria Mercedes Santoro
Journal:  Sci Rep       Date:  2018-10-24       Impact factor: 4.379

8.  The S68G polymorphism is a compensatory mutation associated with the drug resistance mutation K65R in CRF01_AE strains.

Authors:  Shengjia Li; Jinming Ouyang; Bin Zhao; Minghui An; Lin Wang; Haibo Ding; Min Zhang; Xiaoxu Han
Journal:  BMC Infect Dis       Date:  2020-02-11       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.